Skip to main content
. 2018 Apr 6;9(26):18160–18179. doi: 10.18632/oncotarget.24793

Figure 1. miR-193b is downregulated in primary neuroblastoma tumor samples.

Figure 1

(A) 69 neuroblastoma tumor samples, independent of the first cohort, were analyzed by qRT-PCR. In this cohort we also found a significant downregulation of miR-193b in comparison to the oncomiRs (p < 0,0001). (B) 10 different neuroblastoma samples were analyzed by RNA sequencing. The expression of miR-193b-3p was comparable to the expression level of the tumor suppressive miR-34a-5p and significantly lower than the expression of the known oncomiRs miR-92a-3p and miR-17-5p (p < 0,0001).